In our editorial, we discuss 4 problems of prescribing measures in some detail—here an overview of the arguments:
Point A: we show that 0 of 30 population-based studies in UK used RCADS/WHODAS, only 2 PHQ/GAD. Only 1 of 81 intervention studies in young people used PHQ/GAD.

These scales were developed for specific purposes and it makes little sense to use them outside of these.
Point B: reducing scope to a few specific symptoms turns blind eye to complexity, heterogeneity & breadth of mental health problems, limits important insights for research & treatment, and reaffirms contested diagnostic categories the ïŹeld is ready to move beyond (e.g. PHQ=DSM).
Point C & D are self-explanatory, see the table above.

We end the editorial with a few suggestions on how to move forward.
Note that @mirandarwolpert wrote a rejoinder to our piece, which you can find here. We've also been chatting about this in person, & hope to continue these conversations in the future.
/đŸ§” https://twitter.com/mirandarwolpert/status/1290658081014272003
You can follow @EikoFried.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: